FDA approves first at-home COVID-19 test kit

By: |
April 25, 2020 8:57 AM

Earlier this week, Adam Schechter, president and CEO of LabCorp said that its at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time.

The first at-home test kit has been developed by LabCorp.

In a major development, the US Food and Drug Administration has approved the first at-home COVID-19 test kit, which is expected to bring coronavirus testing to the doorsteps of every household. The first at-home test kit has been developed by LabCorp, a US company which has a network of medical laboratories across the country. It costs USD 119 in the United States.

This is a test where under certain circumstances with doctor supervision, a test can be mailed to a patient, and the patient can perform the self-swab and then mail it back and get the results after that time all under the guidance of a licensed physician, FDA Commissioner Stephen M Hahn told reporters at a White House news conference.

Earlier this week, Adam Schechter, president and CEO of LabCorp said that its at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time.

The authorisation permits nasal swab specimens to be collected at home using the test home collection kit if recommended by a healthcare provider after completing a COVID-19 questionnaire, LabCorp said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Night curfew to be clamped in Delhi due to rising Covid-19 cases? Here’s what AAP govt told High Court
2India had estimated 7.4 crore COVID-19 infections by August: ICMR’s 2nd national serosurvey
3Delhi Covid-19 update: HC alarmed at 2,000 deaths in November, tells AAP govt to avoid cash fines for violation